RayOne Galaxy lens: benefits, limitations and how it works
RayOne Galaxy is a full-range, multifocal intraocular lens made by Rayner. Its spiral refractive surface is designed to support distance vision, computer work and near reading after cataract surgery. It is a fixed implant: it does not restore the natural lens’s ability to change focus.
The main attraction is less dependence on glasses across several distances. The main compromise is that haloes, glare and reduced contrast can still occur, and glasses may remain useful for fine print or demanding tasks. This article concerns the established hydrophilic Galaxy and Galaxy Toric; the newer hydrophobic version is a separate generation.
What sort of vision is Galaxy designed to provide?
Distance includes recognising faces and seeing across a room; intermediate vision includes a computer or kitchen bench; near vision includes a phone or book. Studies commonly test distance at 4 m, intermediate at 66 cm and near at 40 cm. Your comfortable reading distance may differ.
The usual aim is good distance vision with useful intermediate and near vision. The target prescription, residual astigmatism, lighting and the health of both eyes affect the result. Very small print, prolonged reading or dim conditions may still require glasses. A broad range on an eye chart is not a guarantee of complete glasses independence.
How does its optical design work?
Galaxy broadens the range of focus by changing how strongly different parts of its optic bend light. The front surface has a smooth spiral refractive profile: its optical power varies around and across the lens, rather than being identical in every direction. The central region favours distance vision; the surrounding spiral tracks extend the useful focus towards intermediate and near distances.
A standard monofocal lens concentrates its useful focus around one distance. Galaxy distributes useful focus over a broader range, so objects at several distances can be seen without the implant moving. The changing surface profile alters the path of light through the lens; it does not make light physically travel around a spiral inside the eye.
Diffractive trifocals use fine stepped rings to direct light into distinct optical orders. Galaxy uses gradually changing refractive power rather than those stepped diffractive rings. Faint ring-like markings in a product image show its subtle surface profile, not deep grooves. The aim is a smoother transition between working distances, although there are still compromises in contrast and possible haloes or glare.
Rayner’s marketing describes the spiral profile as AI-designed. The company says a proprietary artificial-intelligence system trained on patient outcomes helped create the optical pattern. This refers to the design process: the implanted lens contains no AI, electronics or autofocus. AI-assisted development alone does not establish better vision than another lens.
What is the lens made of?
The established Galaxy is a single-piece, foldable implant made from Rayacryl hydrophilic acrylic, with 26% water content at equilibrium. It has an ultraviolet filter and two closed-loop supporting arms, called haptics, that position it in the capsular bag left after cataract removal.
Some ophthalmologists prefer hydrophobic acrylic because of clouding reported with earlier hydrophilic lenses. Calcium-phosphate deposits can form on or within some hydrophilic implants, making the optic cloudy and reducing vision. Reports include several manufacturers and earlier Rayner hydrophilic models; they are not reports of the newer Galaxy lens.
A particular concern is later surgery using air or gas inside the eye, such as retinal surgery with a gas bubble or corneal endothelial transplantation. Calcification has been reported after these procedures, especially repeated air or gas injections, although cases also occur without gas. This is one reason a surgeon may favour hydrophobic acrylic when such surgery is likely.
This material clouding differs from clouding of the capsule behind the implant. YAG laser treats capsule clouding, but cannot clear calcium deposits within the lens; significant calcification may require lens exchange. These reports do not show that all hydrophilic lenses will cloud. Hydrophobic materials also have their own possible issues, including glistenings in some formulations. Read more about hydrophobic versus hydrophilic acrylic lens materials.
Rayner announced a hydrophobic Galaxy in September 2026, with a planned fourth-quarter rollout in CE-mark markets. The studies below should not automatically be transferred to that material.
What are its technical specifications?
The following values concern the hydrophilic models. Dioptres (D) describe lens power. Toric cylinder is quoted at the implant plane, so it is not numerically interchangeable with the astigmatism measured at the cornea.
| Feature | Specification |
|---|---|
| Model identity | |
| Standard / toric | RAO605G / RAO615X |
| Dimensions and construction | |
| Optic / overall span | 6.0 mm / 12.5 mm |
| Material / edge | Rayacryl; 26% water; 360° square posterior edge |
| Haptics | Closed C-loop; 0° angulation |
| Optics and power | |
| Standard power | +5.0 to +30.0 D; 0.5 D steps |
| Toric spherical equivalent | +6.0 to +30.0 D; 0.5 D steps |
| Toric cylinder, implant plane (Australian listing) | +0.75 to +4.50 D; 0.75 D steps |
| Material refractive index / UV filter | 1.46 / UV-filtering |
| Delivery | |
| Preloaded injector | RayOne; capsular bag implantation |
The injector is fully preloaded. Rayner describes a 1.65 mm nozzle and a 2.2 mm incision; the actual wound size depends on surgical technique. These dimensions do not establish faster recovery or a better visual result.
Is there a toric version for astigmatism?
Yes. Hydrophilic Galaxy Toric, model RAO615X, is available in Australia. It adds correction for regular corneal astigmatism while retaining the spiral full-range design. It must be aligned to a planned axis; rotation can reduce the correction and occasionally requires repositioning.
What are the main advantages?
- A wider working range: direct studies support useful intermediate and near vision alongside distance vision.
- Better near performance than a standard monofocal: the US randomised trial demonstrated this when distance prescription was corrected during testing.
- A toric option: suitable regular astigmatism can be addressed within the same focus category.
- A refractive alternative: the spiral design offers a different way of providing multifocal vision from a diffractive trifocal. That distinction alone does not prove superiority.
What are the main limitations and uncertainties?
- Night effects remain possible: haloes, glare and starbursts may be troublesome, particularly around headlights.
- Contrast is a trade-off: a satisfactory eye-chart result does not guarantee equally crisp vision in dim light.
- Glasses may still help: fine print, poor lighting or residual prescription may expose limits in the useful range.
- The whole eye matters: dry eye, corneal irregularity, macular disease or glaucoma may limit the benefit.
- Long-term evidence is developing: the principal direct clinical reports have follow-up of a few months. They cannot settle uncommon late problems or comparisons with every modern lens.
What have clinical studies found?
The strongest comparison is against a monofocal lens, not another full-range lens. In the FDA-reviewed US trial, 230 patients were randomised to bilateral Galaxy or RayOne Aspheric monofocal implantation; 219 attended the 4–6 month visit. Galaxy improved distance-corrected near vision while maintaining good distance vision. Contrast testing met the specified non-inferiority criterion; that does not mean identical contrast.
At that visit, 12 of 110 Galaxy respondents reported haloes “very often”, compared with 1 of 109 monofocal respondents. This measures frequency, not severity or how bothersome the haloes were. The sponsor was Rayner, and follow-up was too short to establish long-term safety.
An earlier multicentre series reported 73 patients with 146 eyes receiving hydrophilic Galaxy or Galaxy Toric. At 3 months, distance-corrected results supported a broad range, but there was no implanted control group. Its separate 30-person vision-simulator comparison with a diffractive trifocal was not a head-to-head trial of implanted lenses. Rayner funded the study and several authors disclosed industry relationships.
A September 2026 observational report followed 49 patients with 98 eyes for 3 months and also found useful distance, intermediate and near performance. It was non-comparative. Together, these findings support the lens’s intended range; they do not prove that everyone will be glasses-free or that Galaxy is the best lens for night driving.
Who might find Galaxy a good fit?
It may suit someone who values a wide range of vision and accepts the possibility of night-time optical symptoms. Assessment should include the tear film, corneal shape, retina, optic nerve and capsular support, rather than lens choice based on glasses preference alone.
Previous laser vision correction, macular disease, glaucoma, irregular astigmatism or weak lens support can change the balance. If night driving or maximum dim-light contrast is your leading priority, discuss a monofocal or another more conservative option. The reason for a recommendation should relate to your eyes and activities.
What are the alternatives?
A standard monofocal usually prioritises one distance, with reading glasses for near work. An enhanced monofocal may add some intermediate range. Extended depth-of-focus lenses, such as Tecnis PureSee or Clareon Vivity, generally favour distance and intermediate tasks, with more reliance on glasses for close reading.
A diffractive trifocal is another approach to distance, intermediate and near vision, also with optical compromises. Carefully selected monovision uses different targets in the two eyes and has its own depth-perception trade-off. The Australian lens guide explains the categories; the lens-choice page puts them into cataract planning.
What risks and follow-up should I understand?
Cataract surgery can cause infection, inflammation, pressure changes, retinal problems or an inaccurate final prescription, regardless of lens brand. Optical adaptation may take time, but persistent poor vision should be assessed rather than automatically attributed to adjustment.
Clouding of the capsule behind an implant, called posterior capsule opacification, is different from deposits within the lens material. A YAG capsulotomy may help capsule clouding, but does not treat every cause of blur or haloes. If lens exchange is being considered, discuss it before opening the posterior capsule, because that can make exchange more complex.
What should I ask before choosing this lens?
- Which exact model and material are being proposed?
- What targets are planned for each eye, and when might I still need glasses?
- How could my cornea, retina or optic nerve affect the result?
- Do I need the toric version, and what happens if it rotates?
- How does this choice fit my night driving, reading distance and lighting?
- What is the plan if the result disappoints, including costs and alternatives?
Sources and further reading
- Rayner: 2025 international portfolio, Galaxy specifications →
- FDA: September 2026 safety and effectiveness assessment →
- FDA: Galaxy professional labelling →
- Abela-Formanek and colleagues: multicentre study, Journal of Refractive Surgery, 2025 →
- Arias-Puente and colleagues: observational report, 2026 →
- Australian government: July 2026 Prescribed List, KG040 and KG042 →
- Rayner: hydrophobic Galaxy announcement, September 2026 →
- BMJ Open Ophthalmology: hydrophilic lens opacification after vitrectomy, 2018 →
- Rayner: AI-assisted spiral design, ESCRS 2024 →
- Yildirim and colleagues: calcification after vitrectomy with gas, 2018 →
- Darcy and colleagues: Australian calcification series after additional eye surgery, 2019 →
- Rayner hydrophilic lens calcification after corneal endothelial transplantation, 2014 →